Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2021 | 10-2020 | 07-2020 | 04-2020 | 01-2020 | |
| Sales | 10,812 | 10,117 | 9,547 | 8,749 | 9,012 |
| Cost of Goods | 4,623 | 5,644 | 5,336 | 5,042 | 4,325 |
| Gross Profit | 6,189 | 4,473 | 4,211 | 3,707 | 4,687 |
| Operating Expenses | 5,830 | 5,110 | 4,523 | 5,780 | 4,579 |
| Operating Income | 982 | 7 | 24 | -2,031 | 433 |
| Other Income | -8 | 9 | 64 | -43 | -14 |
| Pre-tax Income | 974 | 16 | 88 | -2,074 | 419 |
| Income Tax | 15 | 15 | 13 | 92 | 12 |
| Net Income Continuous | 959 | 1 | 75 | -2,166 | 407 |
| Net Income | $959 | $1 | $75 | $-2,166 | $407 |
| EPS Basic Total Ops | 0.07 | 0.00 | 0.01 | -0.18 | 0.03 |
| EPS Basic Continuous Ops | 0.07 | 0.00 | 0.01 | -0.18 | 0.03 |
| EPS Diluted Total Ops | 0.07 | 0.00 | 0.01 | -0.17 | 0.03 |
| EPS Diluted Continuous Ops | 0.07 | 0.00 | 0.01 | -0.18 | 0.03 |
| EBITDA(a) | $1,279 | $314 | $301 | $-1,450 | $652 |